...untreated mice. The researchers generated high- and low-affinity CARs using antibodies Erbitux cetuximab and nimotuzumab (BiomAb-EGFR...

...which observed safety issues in patients receiving a combination of cisplatin, vinorelbine, radiotherapy and nimotuzumab. Nimotuzumab...
...between Biocon and CIMAB, has Indian rights to the product. Laboratorios PiSA markets nimotuzumab as Vecthix...
...Laboratorios PiSA , Guadalajara, Mexico Product: Nimotuzumab ( Vecthix , BiomAb-EGFR ) ( DE-766 , OSAG101...

...YM's CIMYM BioSciences Inc. subsidiary sold its assets related to nimotuzumab to InnoKeys for $2 million...
...80/20 JV between YM and CIMAB S.A. (Havana, Cuba), from which YM had rights to nimotuzumab...
...and CIMAB, has Indian rights to the product. Laboratorios PiSA (Guadalajara, Mexico) markets nimotuzumab as Vecthix...

...tumor necrosis that was deemed possibly related to nimotuzumab. Patients received 150 mg/m 2 IV nimotuzumab...
...between Biocon and CIMAB, has Indian rights to the product. Laboratorios PiSA markets nimotuzumab as Vecthix...
...Bekasi, Indonesia Laboratorios PiSA , Guadalajara, Mexico Product: Nimotuzumab ( Vecthix , BiomAb-EGFR ) ( OSAG101...

...An open-label, Japanese Phase II trial in 37 evaluable patients showed that nimotuzumab plus cisplatin and...
...between Biocon and CIMAB, has Indian rights to the product. Laboratorios PiSA markets nimotuzumab as Vecthix...
...Bekasi, Indonesia Laboratorios PiSA , Guadalajara, Mexico Product: Nimotuzumab ( Vecthix , BiomAb-EGFR ) ( OSAG101...

...12 patients ages 3-13 with diffuse pontine glioma from a pilot compassionate use study of nimotuzumab...
...between Biocon and CIMAB, has Indian rights to the product. Laboratorios PiSA markets nimotuzumab as Vecthix...
...Bekasi, Indonesia Laboratorios PiSA , Guadalajara, Mexico Product: Nimotuzumab ( Vecthix , BiomAb-EGFR ) ( OSAG101...

...Sankyo, including a planned pivotal trial of nimotuzumab in gastric cancer (see BioCentury, Feb 21). Nimotuzumab...
...between Biocon and CIMAB, has Indian rights to the product. Laboratorios PiSA markets nimotuzumab as Vecthix...
...Bekasi, Indonesia Laboratorios PiSA , Guadalajara, Mexico Product: Nimotuzumab ( Vecthix , BiomAb-EGFR )) ( OSAG101...

...Sankyo, including a planned pivotal trial of nimotuzumab in gastric cancer (see BioCentury, Feb 21). Nimotuzumab...
...between Biocon and CIMAB, has Indian rights to the product. Laboratorios PiSA markets nimotuzumab as Vecthix...
...Bekasi, Indonesia Laboratorios PiSA , Guadalajara, Mexico Product: Nimotuzumab ( Vecthix , BiomAb-EGFR )) ( OSAG101...

...TSX:YM; NYSE-A:YMI)/Oncoscience AG/Biocon Ltd. (NSE:BIOCON; BSE:BIOCON)/Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568)/PT Kalbe Farma Tbk. (Indonesia:KLBF) Nimotuzumab...

...nimotuzumab in combination with radiation therapy, cisplatin and vinorelbine in patients with stage III NSCLC. Nimotuzumab...
...between Biocon and CIMAB, has Indian rights to the product. Laboratorios PiSA markets nimotuzumab as Vecthix...
...Bekasi, Indonesia Laboratorios PiSA , Guadalajara, Mexico Product: Nimotuzumab ( Vecthix , BiomAb-EGFR )) ( OSAG101...